# A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults

> **NCT06998004** · PHASE1 · COMPLETED · sponsor: **AstriVax Therapeutics** · enrollment: 112 (actual)

## Conditions studied

- Yellow Fever
- Rabies

## Interventions

- **BIOLOGICAL:** AVX70120 low dose level
- **BIOLOGICAL:** AVX70120 middle dose level
- **BIOLOGICAL:** AVX70120 high dose level
- **BIOLOGICAL:** AVX70481 low dose level
- **BIOLOGICAL:** AVX70481 middle dose level
- **BIOLOGICAL:** AVX70481 high dose level
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06998004
- **Lead sponsor:** AstriVax Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-16
- **Primary completion:** 2026-01-26
- **Final completion:** 2026-01-26
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06998004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06998004, "A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT06998004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*